Meld je aan om op te slaan en updates te ontvangen.
Het bewijs voor Ozempic tegen verslaving
Dhruv Khullar on the latest research on GLP-1 drugs, which, though typically used to manage diabetes and obesity, are showing promise as groundbreaking treatments for addictions of all kinds
Bronartikel
The New Yorker (United States) | Feb 20, 2026
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
Vertaling in behandeling
Vertaling in behandeling
Vertaling in behandeling
Vertaling in behandeling
Vertaling in behandeling
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us